Literature DB >> 31084719

Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.

Teo Soleymani1, Sumaira Z Aasi2, Roberto Novoa2, S Tyler Hollmig2.   

Abstract

Atypical fibroxanthoma and undifferentiated pleomorphic sarcoma, or pleomorphic dermal sarcoma, are rare malignant cutaneous neoplasms existing along a clinicopathologic spectrum. Although these tumors share many similarities, recognition of distinguishing characteristics may predict differences in clinical behavior and outcomes. Salient features defining atypical fibroxanthoma include superficial tumors with minimal high-risk histologic features. Deeper tumors with high-risk histologic features are often clinically aggressive and should be appropriately designated as pleomorphic dermal sarcoma. Surgery remains gold standard in management; tumor extirpation with complete margin control is critical. In the high-risk tumor cohort, comprehensive evaluation and multidisciplinary management is paramount for optimal outcomes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical fibroxanthoma; Cancer; Malignant fibrous histiocytoma; Micrographic surgery; Mohs; Pleomorphic dermal sarcoma; Sarcoma; Undifferentiated pleomorphic sarcoma

Mesh:

Year:  2019        PMID: 31084719     DOI: 10.1016/j.det.2019.02.001

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  6 in total

Review 1.  Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis.

Authors:  Isidro Machado; Francisco Giner; Javier Lavernia; Julia Cruz; Víctor Traves; Celia Requena; Beatriz Llombart; José Antonio López-Guerrero; Antonio Llombart-Bosch
Journal:  Histol Histopathol       Date:  2020-09-04       Impact factor: 2.303

2.  Superficial CD34-positive fibroblastic tumor: report of two cases and review of literature.

Authors:  Xu Mao; Ying-Ying Sun; Ming-Liang Deng; Tao Ma; Lan Yu
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

3.  Pleomorphic dermal sarcoma of the scalp: Review of management and distinguishing features from atypical fibroxanthoma.

Authors:  Alexa J Cohen; Sahithi Talasila; Bojan Lazarevic; Laura Gleason; Viral Patel; Neda Nikbakht
Journal:  JAAD Case Rep       Date:  2022-09-13

4.  Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp.

Authors:  Johannes Zeller; Jurij Kiefer; David Braig; Oscar Winninger; Daniel Kraus; Salome Hagelstein; Steffen U Eisenhardt
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

5.  Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.

Authors:  Viviana Piras; Caterina Ferreli; Laura Atzori; Giampietro Pinna; Luca Pilloni
Journal:  Pathologica       Date:  2020-06

6.  Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.

Authors:  Melike Ak; Abdullah Kahraman; Fabian M Arnold; Patrick Turko; Mitchell P Levesque; Martin Zoche; Egle Ramelyte; Reinhard Dummer
Journal:  Genes (Basel)       Date:  2021-06-25       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.